These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27257822)

  • 1. Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.
    Heininger U; André P; Chlibek R; Kristufkova Z; Kutsar K; Mangarov A; Mészner Z; Nitsch-Osuch A; Petrović V; Prymula R; Usonis V; Zavadska D
    PLoS One; 2016; 11(6):e0155949. PubMed ID: 27257822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of pertussis in the world.
    Galazka A
    World Health Stat Q; 1992; 45(2-3):238-47. PubMed ID: 1462658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pertussis.
    Tan T; Trindade E; Skowronski D
    Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S10-8. PubMed ID: 15876918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems.
    Solano R; Masa-Calles J; Garib Z; Grullón P; Santiago SL; Brache A; Domínguez Á; Caylà JA
    BMC Public Health; 2016 Nov; 16(1):1178. PubMed ID: 27876021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.
    Forsyth KD; Tan T; von König CW; Heininger U; Chitkara AJ; Plotkin S
    Vaccine; 2018 Nov; 36(48):7270-7275. PubMed ID: 30337176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which strategy for pertussis vaccination today?
    Girard DZ
    Paediatr Drugs; 2002; 4(5):299-313. PubMed ID: 11994035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Global Pertussis Initiative: meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010.
    Guiso N; Liese J; Plotkin S
    Hum Vaccin; 2011 Apr; 7(4):481-8. PubMed ID: 21389775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of São Paulo, Brazil.
    Fernandes EG; Sartori AMC; de Soárez PC; Carvalhanas TRMP; Rodrigues M; Novaes HMD
    BMC Infect Dis; 2018 Mar; 18(1):126. PubMed ID: 29534683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.
    Carlsson RM; Trollfors B
    Vaccine; 2009 Sep; 27(42):5709-18. PubMed ID: 19679218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis vaccination and whooping cough: and now what?
    Guiso N
    Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis in Latin America and the Hispanic Caribbean: a systematic review.
    Gentile A; Bricks L; Ávila-Agüero ML; Kfouri RA; Torres JP; Ulloa-Gutierrez R; Glover RE; Sarti E
    Expert Rev Vaccines; 2019 Aug; 18(8):829-845. PubMed ID: 31317794
    [No Abstract]   [Full Text] [Related]  

  • 16. Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.
    Tan T; Dalby T; Forsyth K; Halperin SA; Heininger U; Hozbor D; Plotkin S; Ulloa-Gutierrez R; Wirsing von König CH
    Pediatr Infect Dis J; 2015 Sep; 34(9):e222-32. PubMed ID: 26376316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists.
    Noble GR; Bernier RH; Esber EC; Hardegree MC; Hinman AR; Klein D; Saah AJ
    JAMA; 1987 Mar; 257(10):1351-6. PubMed ID: 3820444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling pertussis: how can we do it? A focus on immunization.
    Martinón-Torres F; Heininger U; Thomson A; Wirsing von König CH
    Expert Rev Vaccines; 2018 Apr; 17(4):289-297. PubMed ID: 29482390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis in infants under one year old: risk markers and vaccination status--a case-control study.
    Zamir CS; Dahan DB; Shoob H
    Vaccine; 2015 Apr; 33(17):2073-8. PubMed ID: 25728322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pertussis surveillance systems in Europe.
    Tozzi AE; Pandolfi E; Celentano LP; Massari M; Salmaso S; Ciofi degli Atti ML;
    Vaccine; 2007 Jan; 25(2):291-7. PubMed ID: 16920230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.